**10. Conclusion**

Medication-related osteonecrosis of the jaw (MRONJ) is a common side effect of antiresorptive drugs, which are administered to cancer patients for bone metastasis, multiple myeloma, and osteoporosis. All necessary oral surgeries in oncology patients should ideally be completed before the initiation of high-dose antiresorptive therapy, and to minimize the development of ONJ in patients at risk, regular dental examinations are encouraged. Oral hygiene should be improved and local infection should be managed as early as possible.
